formaldehyde has been researched along with Reperfusion Injury in 2 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gougat, J | 1 |
Ferrari, B | 1 |
Sarran, L | 1 |
Planchenault, C | 1 |
Poncelet, M | 1 |
Maruani, J | 1 |
Alonso, R | 1 |
Cudennec, A | 1 |
Croci, T | 1 |
Guagnini, F | 1 |
Urban-Szabo, K | 1 |
Martinolle, JP | 1 |
SoubriƩ, P | 1 |
Finance, O | 1 |
Le Fur, G | 1 |
Isaacson, Y | 1 |
Salem, O | 1 |
Shepherd, RE | 1 |
Van Thiel, DH | 1 |
2 other studies available for formaldehyde and Reperfusion Injury
Article | Year |
---|---|
SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin
Topics: Administration, Oral; Analgesics; Animals; Bradykinin B1 Receptor Antagonists; CHO Cells; Cricetinae | 2004 |
Lactobionic acid as an iron chelator: a rationale for its effectiveness as an organ preservant.
Topics: Catalysis; Dimethyl Sulfoxide; Disaccharides; Formaldehyde; Free Radicals; Iron Chelating Agents; Mo | 1989 |